129 related articles for article (PubMed ID: 1446051)
21. The selective estrogen enzyme modulator (SEEM) in breast cancer.
Chetrite GS; Pasqualini JR
J Steroid Biochem Mol Biol; 2001; 76(1-5):95-104. PubMed ID: 11384867
[TBL] [Abstract][Full Text] [Related]
22. Interactive effects of interleukin-6, 17 beta-estradiol and progesterone on growth and 17 beta-hydroxysteroid dehydrogenase activity in human breast carcinoma cells.
Speirs V; Adams EF; Rafferty B; White MC
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):11-5. PubMed ID: 8393337
[TBL] [Abstract][Full Text] [Related]
23. A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17 beta-hydroxysteroid dehydrogenase activity.
Coldham NG; James VH
Int J Cancer; 1990 Jan; 45(1):174-8. PubMed ID: 2298502
[TBL] [Abstract][Full Text] [Related]
24. Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture.
Gompel A; Malet C; Spritzer P; Lalardrie JP; Kuttenn F; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1986 Nov; 63(5):1174-80. PubMed ID: 2428825
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth.
Longman SM; Buehring GC
Cancer; 1987 Jan; 59(2):281-7. PubMed ID: 3802015
[TBL] [Abstract][Full Text] [Related]
26. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms.
Shao ZM; Radziszewski WJ; Barsky SH
Cancer Lett; 2000 Sep; 157(2):133-44. PubMed ID: 10936673
[TBL] [Abstract][Full Text] [Related]
28. 17 Beta-hydroxysteroid dehydrogenase in human breast cancer: analysis of kinetic and clinical parameters.
Leszczynski D; Santner SJ; Feil PD; Santen RJ
Steroids; 1988; 51(3-4):299-316. PubMed ID: 2851200
[TBL] [Abstract][Full Text] [Related]
29. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
31. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
Pasqualini JR
Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
[TBL] [Abstract][Full Text] [Related]
32. Effect of progestins, estradiol, and coenzymes NAD and NADPH on the interconversion of estradiol and estrone in rabbit uterus in vitro.
Murugesan K; Vij U; Lal B; Farooq A
Steroids; 1989 Jun; 53(6):695-712. PubMed ID: 2554542
[TBL] [Abstract][Full Text] [Related]
33. Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study.
Song D; Liu G; Luu-The V; Zhao D; Wang L; Zhang H; Xueling G; Li S; Désy L; Labrie F; Pelletier G
J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):136-44. PubMed ID: 16930994
[TBL] [Abstract][Full Text] [Related]
34. Control of progesterone receptors in fetal uterine cells in culture: effects of estradiol, progestins, antiestrogens, and growth factors.
Sumida C; Lecerf F; Pasqualini JR
Endocrinology; 1988 Jan; 122(1):3-11. PubMed ID: 3275538
[TBL] [Abstract][Full Text] [Related]
35. Estradiol 17 beta-hydroxysteroid dehydrogenase activity in human breast fibroadenomas.
Fournier S; Kuttenn F; de Cicco F; Baudot N; Malet C; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1982 Sep; 55(3):428-33. PubMed ID: 6954155
[TBL] [Abstract][Full Text] [Related]
36. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
37. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
Aka JA; Calvo EL; Lin SX
Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of human placental 17 beta,20 alpha-hydroxysteroid dehydrogenase affinity alkylated by estrone 3-(bromoacetate): topographic studies with 16 alpha-(bromoacetoxy)estradiol 3-(methyl ether).
Thomas JL; LaRochelle MC; Asibey-Berko E; Strickler RC
Biochemistry; 1985 Sep; 24(20):5361-7. PubMed ID: 3865689
[TBL] [Abstract][Full Text] [Related]
39. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552
[TBL] [Abstract][Full Text] [Related]
40. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX
J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
